Published in Am J Trop Med Hyg on May 01, 1990
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol (1998) 1.49
A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol (2000) 1.46
High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol (1992) 1.18
Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother (2013) 0.93
Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice. J Virol (2003) 0.90
Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model. Virol J (2012) 0.86
Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line. Virol J (2007) 0.84
Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene (1989) 2.15
Detection of West Nile virus by the polymerase chain reaction and analysis of nucleotide sequence variation. Am J Trop Med Hyg (1993) 2.07
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Characterization of atypical aerobic gram-negative cocci isolated from humans. J Clin Microbiol (1982) 1.66
Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene (1992) 1.26
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Partial sequence analysis of cloned dengue virus type 2 genome. Gene (1986) 1.21
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine (2011) 1.15
Skeletal changes in patients treated by regular haemodialysis in the Sheffield area. Br J Radiol (1973) 1.14
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans. Am J Trop Med Hyg (1990) 1.08
Hyperoxaluria in adults. Br J Surg (1968) 1.06
Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis (1993) 1.02
Dengue serotypes 2 and 3 in US forces in Somalia. Lancet (1994) 1.02
Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci (1972) 0.97
The absence of 24,25-dihydroxycholecalciferol in anephric patients. Clin Sci Mol Med Suppl (1978) 0.97
Molecular genotyping of dengue viruses by phylogenetic analysis of the sequences of individual genes. J Virol Methods (2008) 0.95
A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions. Virus Genes (1996) 0.94
Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. Am J Trop Med Hyg (1996) 0.94
Some factors influencing the proliferation and differentiation of myelin-forming cells. Neurology (1978) 0.93
Detection of concurrent infection with multiple dengue virus serotypes in Thai children by ELISA and nested RT-PCR assay. Arch Virol (2008) 0.93
Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Vaccine (1992) 0.92
The competitive equilibrium between aluminium and ferric ions for the binding sites of transferrin. FEBS Lett (1984) 0.92
Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay. Am J Clin Pathol (1998) 0.91
Aspects of renal bone disease. Aust N Z J Med (1981) 0.87
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine (1992) 0.87
Detection of dengue virus RNA using nucleic acid hybridization. J Virol Methods (1987) 0.87
Plasma membrane H(+)-HCO3- transport in rat hepatocytes: a principal role for Na(+)-coupled HCO3- transport. Am J Physiol (1991) 0.87
Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series. J Infect Dis (1995) 0.87
Treatment of primary hyperoxaluria with calcium carbimide. N Engl J Med (1967) 0.87
Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood (1992) 0.86
Renal effects of calcitonin. Br Med J (1970) 0.86
Renal tubular acidosis of pyelonephritis with renal stone disease. Br Med J (1968) 0.86
Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. Am J Trop Med Hyg (1991) 0.85
Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants. Vaccine (1999) 0.85
HCO3(-)-coupled Na+ influx is a major determinant of Na+ turnover and Na+/K+ pump activity in rat hepatocytes. J Membr Biol (1991) 0.84
Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells. Am J Trop Med Hyg (1996) 0.84
Purification and renaturation of Japanese encephalitis virus nonstructural glycoprotein NS1 overproduced by insect cells. Protein Expr Purif (1995) 0.84
Effect of correction of metabolic acidosis on bone mineralisation rates in patients with renal osteomalacia. Nephron (1975) 0.83
Technical performance evaluation of BM/Hitachi 747-200 serum fructosamine assay. Clin Chem (1996) 0.83
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy. Mult Scler (2001) 0.83
Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge. Am J Trop Med Hyg (1994) 0.83
Advances in cooled semen technologies: seminal plasma and semen extender. Anim Reprod Sci (2001) 0.82
Direct spectrophotometric determination of the two site binding of aluminum to transferrin. Life Sci (1987) 0.82
The relation between the concentration of calcium salts in the urine and renal stone composition in patients with calcium-containing renal stones. Clin Sci (1972) 0.81
Role of acidosis in renal osteomalacia. Br Med J (1969) 0.81
Limited effect of recombinant porcine interleukin-12 on porcine lymphocytes due to a low level of IL-12 beta2 receptor. Vet Immunol Immunopathol (2002) 0.80
Hypogammaglobulinaemia with Whipple's disease. Postgrad Med J (1973) 0.80
SPECT of the peritoneal cavity: method for delineating intraperitoneal fluid distribution. AJR Am J Roentgenol (1989) 0.79
Ranitidine disposition in patients with renal impairment. Br J Clin Pharmacol (1983) 0.79
Cross sectional and longitudinal study of bone mineral content of the distal forearm in adult premenopausal women. Horm Metab Res (1991) 0.79
Fetal heart rate decelerations during ECT-induced seizures: is it important? Acta Anaesthesiol Scand (2003) 0.78
A new technology in burn therapy: INTEGRA artificial skin. Dimens Crit Care Nurs (2000) 0.78
Hypocalcaemia and bone disease in renal failure. Nephron (1973) 0.78
Expression of the trembler mouse mutation in organotypic cultures of dorsal root ganglia. Brain Res (1982) 0.78
Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 analyzer. Clin Chem (1998) 0.78
Leishmaniasis in the United States military. Mil Med (1998) 0.78
Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine. Vaccine (1999) 0.78
Aluminium interaction with 67Ga uptake by human plasma and transferrin. Clin Chim Acta (1983) 0.77
Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man. Adv Exp Med Biol (1978) 0.77
Binding of Al by protein in plasma of patients on maintenance hemodialysis. Clin Chem (1985) 0.76
The visual connections of the adult flatfish, Achirus lineatus. J Comp Neurol (1975) 0.76
Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to vero cells. DNA Seq (2001) 0.76
How finishing affects glass ionomers. Results of a five-year evaluation. J Am Dent Assoc (1991) 0.76
Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporos Int (2000) 0.75
Acute responsiveness to calcitonin in chronic renal failure. Br Med J (1976) 0.75
PC12 neurite regeneration and long-term maintenance in the absence of exogenous nerve growth factor in response to contact with Schwann cells. Brain Res (1985) 0.75
Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein. Bull World Health Organ (1990) 0.75
Longevity of glass-ionomer restorative materials: results of a 10-year evaluation. Quintessence Int (1996) 0.75
Haemolytic-uraemic syndrome. Lancet (1994) 0.75
Production of chicken chimeras from injection of frozen-thawed blastodermal cells. Poult Sci (1997) 0.75
Differences in density and distribution of surface glycoconjugates between normal and dystrophic mouse Schwann cells detected by statistical analyses of lectin-ferritin binding. Brain Res (1985) 0.75
E.S.W.I.: a shocking blow to kidney stones. Nursing (1987) 0.75
Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS. Clin Lab (2000) 0.75
Phenotypic and functional characterization of normal and malignant terminal B (plasma) cells. Eur J Haematol Suppl (1989) 0.75
Isotopic bone mineralization rates in maintenance dialysis patients. J Lab Clin Med (1983) 0.75
Alternative pathway of bovine complement: concentration of factor B, hemolytic activity and heritability. Vet Immunol Immunopathol (1984) 0.75
Use of structured student-facilitated small groups in a behavioral science/psychiatry course. Acad Med (1998) 0.75
Neurotoxicity of polystyrene containers detected in a closed tissue culture system. Neurosci Lett (1980) 0.75
Prognosis of cadaver kidney grafts with a rejection episode occurring within 2 weeks of transplantation. Transplantation (1979) 0.75
Addressing youth and family vulnerability: empowerment in an ecological context. Can J Public Health (1989) 0.75
Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients. Calcif Tissue Int (1994) 0.75
A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. Isr J Med Sci (1994) 0.75
Fibrinous pericarditis and fibrinolysis in chronic dialysis patients. Clin Nephrol (1979) 0.75
Identification of hepatitis E virus in clinical specimens: amplification of hydroxyapatite-purified virus RNA and restriction endonuclease analysis. J Virol Methods (1997) 0.75
Schwann cells fail to differentiate when co-cultured in contact with PC12 neurites. Brain Res (1985) 0.75
Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice. Am J Trop Med Hyg (1992) 0.75
Clinical evaluation and early finishing of glass ionomer restorative materials. Oper Dent (1988) 0.75
Adenocarcinoma of the alimentary tract: peritoneal distribution scintigraphy. Radiology (1987) 0.75
Some characteristics of 17 beta-estradiol dehydrogenase from bovine placenta. Steroids (1979) 0.75
Panhypopituitarism, testicular atrophy, alactasia, corticosteroid-induced osteoporosis and systemic lupus erythematosus induced by methoin. Proc R Soc Med (1968) 0.75
The causes of hypocalcaemia in chronic renal failure. Clin Sci (1971) 0.75
Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines. Isr J Med Sci (1971) 0.75